ResearcherPeking UniversityActive in the last 2 years

Siru Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-8505-9231. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

K11- and K29-ubiquitination-mediated nuclear translocation of glycolytic enzyme aldolase A promotes pancreatic cancer progression by NF-κB activation. Co-author DOI 10.1038/s41418-025-01592-7 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuhan Zhao · 1 shared paper, 2026 · strength 0.39
- Paper K11- and K29-ubiquitination-mediated nuclear translocation of glycolytic enzyme aldolase A promotes pancreatic cancer p… DOI 10.1038/s41418-025-01592-7 ↗
Xiaofeng Zheng · 1 shared paper, 2026 · strength 0.39
- Paper K11- and K29-ubiquitination-mediated nuclear translocation of glycolytic enzyme aldolase A promotes pancreatic cancer p… DOI 10.1038/s41418-025-01592-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.